Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
M Treskova-Schwarzbach, L Haas, S Reda, A Pilic… - BMC medicine, 2021 - Springer
Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …
Short and long-term impact of COVID-19 infection on previous respiratory diseases
E Chiner-Vives, R Cordovilla-Perez… - Archivos de …, 2022 - Elsevier
Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …
Difference in SARS-CoV-2 antibody status between patients with cancer and health care workers during the COVID-19 pandemic in Japan
S Yazaki, T Yoshida, Y Kojima, S Yagishita… - JAMA …, 2021 - jamanetwork.com
Importance Patients with cancer and health care workers (HCWs) are at high risk of SARS-
CoV-2 infection. Assessing the antibody status of patients with cancer and HCWs can help …
CoV-2 infection. Assessing the antibody status of patients with cancer and HCWs can help …
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
Background The COVID-19 has caused significant mortality and morbidity across the globe.
Patients with cancer are especially vulnerable given their immunocompromised state. We …
Patients with cancer are especially vulnerable given their immunocompromised state. We …
Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: a population‐based multistate cohort study including 4 618 377 adults in …
The relationship between cancer and coronavirus disease 2019 (COVID‐19) infection and
severity remains poorly understood. We conducted a population‐based cohort study …
severity remains poorly understood. We conducted a population‐based cohort study …
Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
YB Shah, S Kjelstrom, D Martinez… - Cancer …, 2023 - Wiley Online Library
Background The COVID‐19 pandemic has disrupted medical care, increased isolation, and
exacerbated anxiety in breast cancer patients. Since March 2020, Breastcancer. org …
exacerbated anxiety in breast cancer patients. Since March 2020, Breastcancer. org …
Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis
Cancer patients are more vulnerable to COVID-19 compared to the general population, but it
remains unclear which types of cancer have the highest risk of COVID-19-related mortality …
remains unclear which types of cancer have the highest risk of COVID-19-related mortality …
Impact of immune checkpoint inhibitors on COVID-19 severity in patients with cancer
R Tan, C Yun, A Seetasith, D Sheinson, R Walls… - The …, 2022 - academic.oup.com
Background Amid continued uncertainty about the management of cancer patients during
the pandemic, this study sought to obtain real-world data on the use of immune checkpoint …
the pandemic, this study sought to obtain real-world data on the use of immune checkpoint …
Updated COVID‐19 clearance time among patients with cancer in the Delta and Omicron waves
Background COVID‐19 infection delays therapy and in‐person evaluation for oncology
patients, but clinic clearance criteria are not clearly defined. Methods We conducted a …
patients, but clinic clearance criteria are not clearly defined. Methods We conducted a …
Modifiable contributing factors to COVID-19: A comprehensive review
RN Kostoff, MB Briggs, D Kanduc, S Dewanjee… - Food and Chemical …, 2023 - Elsevier
The devastating complications of coronavirus disease 2019 (COVID-19) result from an
individual's dysfunctional immune response following the initial severe acute respiratory …
individual's dysfunctional immune response following the initial severe acute respiratory …